Loading
A phase 3 trial in lung cancer, run by Georgetown University, now recruiting.
Tobacco Education and Lung Health Study (TEAL) is a phase 3, randomised interventional study registered as NCT06290869 by Georgetown University, with a registry enrolment figure of 1188 participants, started 2024-02-22 and due to reach its primary completion in 2027-12-01. Interventions recorded: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention; E-Referral to the Tobacco Quitline. Conditions listed: Smoking Cessation. Primary outcome: Biochemically verified smoking abstinence- MHS vs. QL-E arms; Biochemically verified smoking abstinence--continued MHS arm vs Stepped Care. Lung eligibility wording from the registry: "* prior lung cancer,". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.